Literature DB >> 21723877

Vascular dysfunction and impaired insulin signaling in high-fat diet fed ovariectomized mice.

Koji Tominaga1, Atsushi Yamauchi, Takashi Egawa, Ryosuke Tanaka, Satoko Kawahara, Hideki Shuto, Yasufumi Kataoka.   

Abstract

The metabolic syndrome, characterized by conditions such as obesity and insulin resistance, is more prevalent in postmenopausal women than in premenopausal women, and increases the risk of cardiovascular disease and type 2 diabetes. The main objective of the present study was to investigate the combined effects of ovariectomy (OVX) and high-fat diet (HFD) on metabolic parameters, vascular function and glucose homeostasis in mice. After OVX or sham operation (Sham), mice were fed with either a normal diet (ND) or a HFD. Mice were divided into ND+Sham, ND+OVX, HFD+Sham, and HFD+OVX groups. After 4weeks, HFD+OVX mice developed marked increases in body weight and plasma insulin levels, but not blood glucose levels. The area under the glucose tolerance curve (Δ AUC(glucose)) following an oral glucose tolerance test and the homeostasis model assessment of insulin resistance (HOMA-IR) revealed that HFD+OVX mice had higher values than any other group. Concomitantly with these metabolic disturbances, decreased tail skin blood flow and augmented tail skin flushing, a marker of hot flashes, were observed in HFD+OVX mice. These vascular modulations likely result from vasomotor dysfunction. Furthermore, we investigated whether OVX and HFD affect the insulin signaling pathway in mice. Insulin-induced Akt phosphorylation in the livers of HFD+OVX mice was significantly downregulated compared with ND+Sham and HFD+Sham mice. Thus, the HFD+OVX mice used in the present study constitute an experimental animal model of postmenopausal metabolic syndrome. Herein, we provide experimental evidence that vascular dysfunction and impaired insulin signaling may contribute to the pathogenesis of postmenopausal metabolic syndrome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723877     DOI: 10.1016/j.mvr.2011.06.004

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  2 in total

1.  17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation.

Authors:  Dhaval Sharad Bendale; Pinakin Arun Karpe; Richa Chhabra; Sachin Prabhakarrao Shete; Heta Shah; Kulbhushan Tikoo
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

2.  A Hop Extract Lifenol® Improves Postmenopausal Overweight, Osteoporosis, and Hot Flash in Ovariectomized Rats.

Authors:  Young-Hwan Ban; Jung-Min Yon; Yeseul Cha; Jieun Choi; Eun Suk An; Haiyu Guo; Da Woom Seo; Tae-Su Kim; Sung-Pyo Lee; Jong-Choon Kim; Ehn-Kyoung Choi; Yun-Bae Kim
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-12       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.